Search

Your search keyword '"Rao, Sunil V."' showing total 1,265 results
Start Over Author "Rao, Sunil V." Search Limiters Full Text
1,265 results on '"Rao, Sunil V."'

1. The Path to a Match for Interventional Cardiology Fellowship: A Major SCAI Initiative

Author

Drachman, Douglas E., Addo, Tayo, Applegate, Robert J., Bartel, Robert C., Bortnick, Anna E., Dea, Francesca M., Helmy, Tarek, Henry, Timothy D., Khalif, Adnan, Kirtane, Ajay J., Levy, Michael, Lim, Michael J., Mahmud, Ehtisham, Mihatov, Nino, Parikh, Sahil A., Porter, Laura, Prasad, Abhiram, Rao, Sunil V., Razzouk, Louai, Shah, Samit, Shroff, Adhir, Tamis-Holland, Jacqueline E., Velagapudi, Poonam, Welt, Fredrick G., and Abbott, J. Dawn

Published
2024
Full Text
View/download PDF

5. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review

Author

Gaudino, Mario, Di Franco, Antonino, Arbustini, Eloisa, Bacha, Emile, Bates, Eric R., Cameron, Duke E., Cao, Davide, David, Tirone E., De Paulis, Ruggero, El-Hamamsy, Ismail, Farooqi, Kanwal M., Girardi, Leonard N., Gräni, Christoph, Kochav, Jonathan D., Molossi, Silvana, Puskas, John D., Rao, Sunil V., Sandner, Sigrid, Tatoulis, James, Truong, Quynh A., Weinsaft, Jonathan W., Zimpfer, Daniel, and Mery, Carlos M.

Published
2023
Full Text
View/download PDF

8. International Psychological Well-Being Survey of Interventional Cardiologists

Author

Simsek, Bahadir, Rempakos, Athanasios, Kostantinis, Spyridon, Karacsonyi, Judit, Rangan, Bavana V., Mastrodemos, Olga C., Kirtane, Ajay J., Bortnick, Anna E., Jneid, Hani, Azzalini, Lorenzo, Milkas, Anastasios, Alaswad, Khaldoon, Linzer, Mark, Egred, Mohaned, Allana, Salman S., Rao, Sunil V., Sandoval, Yader, and Brilakis, Emmanouil S.

Published
2023
Full Text
View/download PDF

11. Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial

Author

Oqab, Zardasht, Kunadian, Vijay, Wood, David A., Storey, Robert F., Rao, Sunil V., Mehran, Roxana, Pinilla-Echeverri, Natalia, Mani, Thenmozhi, Boone, Robert H., Kassam, Saleem, Bossard, Matthias, Mansour, Samer, Ball, Warren, Sibbald, Matthew, Valettas, Nicholas, Moreno, Raul, Steg, Philippe Gabriel, Cairns, John A., and Mehta, Shamir R.

Published
2023
Full Text
View/download PDF

17. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Author

Capodanno, Davide, Mehran, Roxana, Krucoff, Mitchell W., Baber, Usman, Bhatt, Deepak L., Capranzano, Piera, Collet, Jean-Philippe, Cuisset, Thomas, De Luca, Giuseppe, De Luca, Leonardo, Farb, Andrew, Franchi, Francesco, Gibson, C. Michael, Hahn, Joo-Yong, Hong, Myeong-Ki, James, Stefan, Kastrati, Adnan, Kimura, Takeshi, Lemos, Pedro A., Lopes, Renato D., Magee, Adrian, Matsumura, Ryosuke, Mochizuki, Shuichi, O’Donoghue, Michelle L., Pereira, Naveen L., Rao, Sunil V., Rollini, Fabiana, Shirai, Yuko, Sibbing, Dirk, Smits, Peter C., Steg, P. Gabriel, Storey, Robert F., ten Berg, Jurrien, Valgimigli, Marco, Vranckx, Pascal, Watanabe, Hirotoshi, Windecker, Stephan, Serruys, Patrick W., Yeh, Robert W., Morice, Marie-Claude, and Angiolillo, Dominick J.

Published
2023
Full Text
View/download PDF

18. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021.

Author

Naidu, Srihari S., Baran, David A., Jentzer, Jacob C., Hollenberg, Steven M., van Diepen, Sean, Basir, Mir B., Grines, Cindy L., Diercks, Deborah B., Hall, Shelley, Kapur, Navin K., Kent, William, Rao, Sunil V., Samsky, Marc D., Thiele, Holger, Truesdell, Alexander G., and Henry, Timothy D.

Published
2022
Full Text
View/download PDF

20. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Author

Lawton, Jennifer S., Tamis-Holland, Jacqueline E., Bangalore, Sripal, Bates, Eric R., Beckie, Theresa M., Bischoff, James M., Bittl, John A., Cohen, Mauricio G., DiMaio, J. Michael, Don, Creighton W., Fremes, Stephen E., Gaudino, Mario F., Goldberger, Zachary D., Grant, Michael C., Jaswal, Jang B., Kurlansky, Paul A., Mehran, Roxana, Metkus, Thomas S., Jr., Nnacheta, Lorraine C., Rao, Sunil V., Sellke, Frank W., Sharma, Garima, Yong, Celina M., and Zwischenberger, Brittany A.

Published
2022
Full Text
View/download PDF

21. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Author

Lawton, Jennifer S., Tamis-Holland, Jacqueline E., Bangalore, Sripal, Bates, Eric R., Beckie, Theresa M., Bischoff, James M., Bittl, John A., Cohen, Mauricio G., DiMaio, J. Michael, Don, Creighton W., Fremes, Stephen E., Gaudino, Mario F., Goldberger, Zachary D., Grant, Michael C., Jaswal, Jang B., Kurlansky, Paul A., Mehran, Roxana, Metkus, Thomas S., Jr., Nnacheta, Lorraine C., Rao, Sunil V., Sellke, Frank W., Sharma, Garima, Yong, Celina M., and Zwischenberger, Brittany A.

Published
2022
Full Text
View/download PDF

23. A quality framework for the role of invasive, non-interventional cardiologists in the present-day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement.

Author

Mulukutla, Suresh R, Babb, Joseph D, Baran, David A, Boudoulas, Konstantinos D, Feldman, Dmitriy N, Hall, Shelley A, Jennings, Henry S, 3rd, Kapur, Navin K, Rao, Sunil V, Reginelli, Joel, Schussler, Jeffrey M, Yang, Eric H, and Cigarroa, Joaquin E

Abstract

The present-day cardiac catheterization laboratory (CCL) is home to varied practitioners who perform both diagnostic, interventional, and complex invasive procedures. Invasive, non-interventional cardiologists are performing a significant proportion of the work as the CCL environment has evolved. This not only includes those who perform diagnostic-only cardiac catheterization but also heart failure specialists who may be involved in hemodynamic assessment and in mechanical circulatory support and pulmonary hypertension specialists and transplant cardiologists. As such, the training background of those who work in the CCL is varied. While most quality metrics in the CCL are directed towards evaluation of patients who undergo traditional interventional procedures, there has not been a focus upon providing these invasive, noninterventional cardiologists, hospital/CCL administrators, and CCL directors a platform for quality metrics. This document focuses on benchmarking quality for the invasive, noninterventional practice, providing this physician community with guidance towards a patient-centered approach to care, and offering tools to the invasive, noninterventionalists to help their professional growth. This consensus statement aims to establish a foundation upon which the invasive, noninterventional cardiologists can thrive in the CCL environment and work collaboratively with their interventional colleagues while ensuring that the highest quality of care is being delivered to all patients.

Published
2018

24. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial

Author

Brilakis, Emmanouil S, Edson, Robert, Bhatt, Deepak L, Goldman, Steven, Holmes, David R, Rao, Sunil V, Shunk, Kendrick, Rangan, Bavana V, Mavromatis, Kreton, Ramanathan, Kodangudi, Bavry, Anthony A, Garcia, Santiago, Latif, Faisal, Armstrong, Ehrin, Jneid, Hani, Conner, Todd A, Wagner, Todd, Karacsonyi, Judit, Uyeda, Lauren, Ventura, Beverly, Alsleben, Aaron, Lu, Ying, Shih, Mei-Chiung, Banerjee, Subhash, Investigators, DIVA Trial, Ahmed, Bina, Ratliff, D Michelle, Ricciardi, Mark, Sheldon, Mark, Icenogle, Milton, Snider, Richard, Ardati, Amer, Nallamothu, Brahmajee, Duvernoy, Claire, Menees, Daniel S, Gurm, Hitinder, Thomas, Michael P, Grossman, Paul, Owen, Kristine, Topaz, On, Kumar, Gautam, Block, Peter, Zidar, David A, Bezerra, Hiram, Goldberg, Jonathan, Ortiz, Jose, Jozic, Joseph, Osman, Mohammed, Rosenthal, Noah, Parikh, Sahil A, Lassar, Tom A, Chan, Albert, Kumar, Arun, Aggarwal, Kul, Cyrus, Tillmann, Grodin, Jerrold, Hattler, Brack, Casserly, Ivan, Messenger, John, Kim, Michael, Rogers, R Kevin, Waldo, Stephen, Tsai, Thomas, Morris, Kenneth, Krucoff, Mitchell, Rao, Sunil, Povsic, Thomas J, Jones, William S, Bavry, Anthony, Choi, Calvin, Park, Ki, Liu, Jayson, Kar, Biswajit, Paniagua, David, Breall, Jeffrey, Bolad, Islam, Mukerji, Rita, Subbarao, Roopa, Abdel-Latif, Ahmed, Booth, David C, Ziada, Khaled M, Rajan, Lawrence, Hakeem, Abdul, Uretsky, Barry F, Agrawal, Mayank, Sachdeva, Rajesh, Ahmed, Zubair, McGee, Jesse, Shah, Rahman, Sharma, Alok, McFalls, Edward, Siddiqui, Rizwan, and Adabag, Selcuk

Subjects
Cardiovascular, Bioengineering, Clinical Research, Heart Disease, Clinical Trials and Supportive Activities, Patient Safety, Assistive Technology, Atherosclerosis, Heart Disease - Coronary Heart Disease, Aged, Double-Blind Method, Drug-Eluting Stents, Female, Graft Rejection, Humans, Male, Middle Aged, Percutaneous Coronary Intervention, Saphenous Vein, Self Expandable Metallic Stents, Thrombosis, Treatment Outcome, DIVA Trial Investigators, Medical and Health Sciences, General & Internal Medicine
Abstract

BackgroundFew studies have examined the efficacy of drug-eluting stents (DES) for reducing aortocoronary saphenous vein bypass graft (SVG) failure compared with bare-metal stents (BMS) in patients undergoing stenting of de-novo SVG lesions. We assessed the risks and benefits of the use of DES versus BMS in de-novo SVG lesions.MethodsPatients were recruited to our double-blind, randomised controlled trial from 25 US Department of Veterans Affairs centres. Eligible participants were aged at least 18 years and had at least one significant de-novo SVG lesion (50-99% stenosis of a 2·25-4·5 mm diameter SVG) requiring percutaneous coronary intervention with intent to use embolic protection devices. Enrolled patients were randomly assigned, in a 1:1 ratio, by phone randomisation system to receive a DES or BMS. Randomisation was stratified by presence or absence of diabetes and number of target SVG lesions requiring percutaneous coronary intervention (one or two or more) within each participating site by use of an adaptive scheme intended to balance the two stent type groups on marginal totals for the stratification factors. Patients, referring physicians, study coordinators, and outcome assessors were masked to group allocation. The primary endpoint was the 12-month incidence of target vessel failure, defined as the composite of cardiac death, target vessel myocardial infarction, or target vessel revascularisation. The DIVA trial is registered with ClinicalTrials.gov, number NCT01121224.FindingsBetween Jan 1, 2012, and Dec 31, 2015, 599 patients were randomly assigned to the stent groups, and the data for 597 patients were used. The patients' mean age was 68·6 (SD 7·6) years, and 595 (>99%) patients were men. The two stent groups were similar for most baseline characteristics. At 12 months, the incidence of target vessel failure was 17% (51 of 292) in the DES group versus 19% (58 of 305) in the BMS group (adjusted hazard ratio 0·92, 95% CI 0·63-1·34, p=0·70). Between-group differences in the components of the primary endpoint, serious adverse events, or stent thrombosis were not significant. Enrolment was stopped before the revised target sample size of 762 patients was reached.InterpretationIn patients undergoing stenting of de-novo SVG lesions, no significant differences in outcomes between those receiving DES and BMS during 12 months of follow-up were found. The study results have important economic implications in countries with high DES prices such as the USA, because they suggest that the lower-cost BMS can be used in SVG lesions without compromising either safety or efficacy.FundingUS Department of Veterans Affairs Cooperative Studies Program.

Published
2018

25. Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction

Author

Park, Dae Yong, primary, Jamil, Yasser, additional, Ahmad, Yousif, additional, Coles, Theresa, additional, Bosworth, Hayden Barry, additional, Sikand, Nikhil, additional, Davila, Carlos, additional, Babapour, Golsa, additional, Damluji, Abdulla A., additional, Rao, Sunil V., additional, Nanna, Michael G., additional, and Samsky, Marc D., additional

Published
2024
Full Text
View/download PDF

26. Coronary Microvascular Dysfunction

Author

Sandoval, Yader, primary, Cigarroa, Joaquin E., additional, Dangas, George D., additional, Lansky, Alexandra J., additional, Naidu, Srihari S., additional, Rao, Sunil V., additional, Seto, Arnold H., additional, Shah, Samit, additional, Shroff, Adhir R., additional, Toleva, Olga, additional, Tremmel, Jennifer A., additional, Riley, Robert F., additional, Henry, Timothy D., additional, Baumgard, Connie S., additional, Bijoux, Ilka, additional, Cavaliere, Lisa, additional, Culbertson, Casey, additional, Deible, Regina, additional, El-Sabban, Maya, additional, Jackson, Jeremy, additional, Jackson, Melissa, additional, Kalich, Bethany, additional, Long, Vanessa, additional, Newell, Amy, additional, Perkins, Daya, additional, Ramakrishnan, Krish, additional, Russell, Karen, additional, Sharma, Vinod, additional, West, Nick E.J., additional, Whalen-Morton, Chrissy, additional, Underwood, Paul, additional, Winterfeldt, Kristi, additional, Wojcik, Cezary, additional, and Zizzo, Steve, additional

Published
2024
Full Text
View/download PDF

33. Splanchnic Nerve Block for Chronic Heart Failure

Author

Fudim, Marat, Boortz-Marx, Richard L., Ganesh, Arun, DeVore, Adam D., Patel, Chetan B., Rogers, Joseph G., Coburn, Aubrie, Johnson, Inneke, Paul, Amanda, Coyne, Brian J., Rao, Sunil V., Gutierrez, J. Antonio, Kiefer, Todd L., Kong, David F., Green, Cynthia L., Jones, W. Schuyler, Felker, G. Michael, Hernandez, Adrian F., and Patel, Manesh R.

Published
2020
Full Text
View/download PDF

35. Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention: An International Consensus Paper

Author

Bernat, Ivo, Aminian, Adel, Pancholy, Samir, Mamas, Mamas, Gaudino, Mario, Nolan, James, Gilchrist, Ian C., Saito, Shigeru, Hahalis, George N., Ziakas, Antonio, Louvard, Yves, Montalescot, Gilles, Sgueglia, Gregory A., van Leeuwen, Maarten A.H., Babunashvili, Avtandil M., Valgimigli, Marco, Rao, Sunil V., and Bertrand, Olivier F.

Published
2019
Full Text
View/download PDF

36. A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20–200ng/mL

Author

Price, Elizabeth, Artz, Andrew S, Barnhart, Huiman, Sapp, Shelly, Chelune, Gordon, Ershler, William B, Walston, Jeremy D, Gordeuk, Victor R, Berger, Nathan A, Reuben, David, Prchal, Josef, Rao, Sunil V, Roy, Cindy N, Supiano, Mark A, Schrier, Stanley L, and Cohen, Harvey Jay

Subjects
Aging, Hematology, Clinical Trials and Supportive Activities, Clinical Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Aged, Aged, 80 and over, Anemia, Cognition, Drug Administration Schedule, Exercise Test, Female, Ferric Compounds, Ferric Oxide, Saccharated, Ferritins, Glucaric Acid, Humans, Injections, Intravenous, Male, Psychological Tests, Quality of Life, Walking, Unexplained anemia, Hemoglobin, Intravenous iron, 6-Minute walk test, Clinical Sciences, Immunology
Abstract

Anemia is common in older persons and is associated with substantial morbidity and mortality. One third of anemic older adults have unexplained anemia of the elderly (UAE). We carried out a randomized, wait list control trial in outpatients with UAE and serum ferritin levels between 20 and 200 ng/mL. Intravenous iron sucrose was given as a 200-mg weekly dose for 5 weeks either immediately after enrollment (immediate intervention group) or following a 12-week wait list period (wait list control group). The primary outcome measure was changed in 6-minute walk test (6MWT) distances from baseline to 12 weeks between the two groups. Hematologic, physical, cognitive, and quality of life parameters were also assessed. The study was terminated early after 19 subjects enrolled. The distance walked in the 6MWT increased a mean 8.05±55.48 m in the immediate intervention group and decreased a mean 11.45±49.46 m in the wait list control group (p=0.443). The hemoglobin increased a mean 0.39±0.46 g/dL in the immediate intervention group and declined a mean 0.39±0.85 g/dL in the wait list control group (p=0.026). Thus, a subgroup of adults with UAE may respond to intravenous iron. Enrollment of subjects into this type of study remains challenging.

Published
2014

39. Management of Adults With Anomalous Aortic Origin of the Coronary Arteries

Author

Gaudino, Mario, primary, Di Franco, Antonino, additional, Arbustini, Eloisa, additional, Bacha, Emile, additional, Bates, Eric R., additional, Cameron, Duke E., additional, Cao, Davide, additional, David, Tirone E., additional, De Paulis, Ruggero, additional, El-Hamamsy, Ismail, additional, Farooqi, Kanwal M., additional, Girardi, Leonard N., additional, Gräni, Christoph, additional, Kochav, Jonathan D., additional, Molossi, Silvana, additional, Puskas, John D., additional, Rao, Sunil V., additional, Sandner, Sigrid, additional, Tatoulis, James, additional, Truong, Quynh A., additional, Weinsaft, Jonathan W., additional, Zimpfer, Daniel, additional, and Mery, Carlos M., additional

Published
2023
Full Text
View/download PDF

42. No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial

Author

d'Entremont, Marc-André, primary, Alazzoni, Ashraf, additional, Dzavik, Vladimir, additional, Sharma, Vinoda, additional, Overgaard, Christopher B., additional, Lemaire-Paquette, Samuel, additional, Lamelas, Pablo, additional, Cairns, John A., additional, Mehta, Shamir R., additional, Natarajan, Madhu K., additional, Sheth, Tej N., additional, Schwalm, John-David, additional, Rao, Sunil V., additional, Stankovic, Goran, additional, Kedev, Sasko, additional, Moreno, Raul, additional, Cantor, Warren J., additional, Lavi, Shahar, additional, Bertrand, Olivier F., additional, Nguyen, Michel, additional, Couture, Étienne L., additional, and Jolly, Sanjit S., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results